
TRACON Pharmaceuticals Investor Relations Material
Latest events

Q1 2024
TRACON Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from TRACON Pharmaceuticals Inc
Access all reports
TRACON Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing targeted therapies for cancer. The company’s approach includes working with partners to advance drug candidates that address unmet medical needs in oncology. TRACON's pipeline consists of small molecules and biologics designed to treat various cancer types by inhibiting tumor growth and progression. The company also offers its expertise in clinical development and regulatory management to support its collaborations. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
TCON
Country
🇺🇸 United States